At the end of May, the Medicines Patent Pool (MPP) shared on their website that they have entered into negotiations on sutezolid with an unnamed “research based university”. While the MPP has not named the university, we think it’s safe to assume that it is Johns Hopkins given our ongoing campaign to work with the university, the MPP, and the TB Alliance to reach an agreement for sutezolid.

Recent Update on the Sutezolid Campaign at Johns Hopkins University

Madhur Sachan from UAEM India asks the panel if they will move to negotiate a global R&D agreement.

Our Focus

Innovation

Access

Empowerment

Our News


A SHORT VIDEO BY UAEM STUDENTS ON How to fix our R&D system


UAEM calls for alternative R&D!

sticker proofOn February 24th, 2016 Universities Allied for Essential Medicines (UAEM) launched Re:Route, a mapping of alternative biomedical research and development (R&D) initiatives. Launched in time for the United Nations High Level Panel on Access to Medicines dialogue in March 2016, Re:Route  provides a qualitative review of alternative biomedical R&D initiatives around the world. This student-driven project provides evidence of the need to start a truly game changing dialogue that focuses efforts on people oriented and needs-driven biomedical R&D. Click here to learn more.

Join the conversation